13F HOLDINGS REPORT
Aquilo Capital Management, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001645721-23-000012
Total Value
$110.4M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 908,474 | $24.4M | 22.12% |
| 2 | BLUEPRINT MEDICINES CORP | 09627Y109 | 379,090 | $19.0M | 17.25% |
| 3 | REGENXBIO INC | RGNX | 847,424 | $13.9M | 12.64% |
| 4 | SILENCE THERAPEUTICS PLC | SLNCF | 1,312,233 | $12.9M | 11.68% |
| 5 | KYMERA THERAPEUTICS INC | KYMR | 782,219 | $10.9M | 9.85% |
| 6 | MERUS N V | N5749R100 | 430,109 | $10.1M | 9.19% |
| 7 | ARVINAS INC | ARVN | 489,153 | $9.6M | 8.71% |
| 8 | C4 THERAPEUTICS INC | CCCC | 1,990,334 | $3.7M | 3.35% |
| 9 | GENMAB A/S | GNMSF | 52,148 | $1.8M | 1.67% |
| 10 | ARGENX SE | ARGX | 3,715 | $1.8M | 1.66% |
| 11 | OLEMA PHARMACEUTICALS INC | OLMA | 88,875 | $1.1M | 0.99% |
| 12 | PIERIS PHARMACEUTICALS INC | 720795103 | 3,303,190 | $984,351 | 0.89% |